<DOC>
	<DOCNO>NCT00684489</DOCNO>
	<brief_summary>Plasma renin value determine whether volume vasoconstrictor ( renin ) factor predominate elevate blood pressure useful select effective antihypertensive therapy.2,3 The researcher hypothesize : 1 . Plasma renin-guided therapeutic improve systolic diastolic blood pressure control patient untreated hypertension well patient treatment refractory resistant hypertension manage Clinical Hypertension Specialists . 2 . Renin-guided therapeutic reduce number medication require maintain blood pressure control &lt; 140/90 mmHg hypertensive patient receive 3 medication , care Clinical Hypertension Specialist . 3 . Renin-guided therapeutic selection reduce total cost antihypertensive care provide Clinical Hypertension Specialists .</brief_summary>
	<brief_title>Renin-Guided Therapeutics Management Untreated , Uncontrolled , Complicated Hypertension</brief_title>
	<detailed_description>Hypertension affect ~25 % adult . The prevalence hypertension relate complication great among elderly , obese , ethnic minority . Unfortunately , hypertension control rate remain 25 % range often significantly low high-risk group noted.1 Since high-risk group grow rapidly general population , prevalence hypertension associate morbidity mortality probably increase sharply year ahead unless successful strategy implement dramatically improve blood pressure control . Direct measurement plasma renin reflect relative balance volume ( V ) vasoconstrictor ( renin [ R ] ) factor underlie elevate blood pressure patient essential hypertension.2 While many antihypertensive medication effect volume ( V ) vasoconstrictor ( renin [ R ] ) component elevate blood pressure , one usually predominate</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Coal Tar</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<mesh_term>Antihypertensive Agents</mesh_term>
	<criteria>Age , 21 year age old Male female ( postmenopausal effective method birth control ) BP treatment criterion note Willingness provide write , informed consent Ability adhere study protocol Uncontrolled diabetes hyperlipidemia require medication change Any active disease process require new diagnostic therapeutic plan Any lifethreatening illness History alcohol drug abuse past 5 year Mental illness personality disorder interfere adherence study protocol Serum creatinine &gt; 2.5 mg/dL unless document stable least one year Dialysis chronic renal failure , even creatinine stable least one year Intolerance two class antihypertensive medication Normal home BP ( &lt; 140/90 mmHg baseline ) , i.e. , office hypertension .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>hypertension</keyword>
	<keyword>renin-guided therapeutic</keyword>
</DOC>